Synta to Present at the Deutsche Bank 2012 dbAccess BioFEST
Deutsche Bank 2012 dbAccess BioFEST
LEXINGTON, Mass. -- November 27, 2012
Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company
will present at the Deutsche Bank 2012 dbAccess BioFEST on Monday, December 3
at 10:45 a.m. (EST) in Boston.
A live audio webcast and replay of the presentation will be available on the
"Investors" section of the Company's website, www.syntapharma.com.
About Synta Pharmaceuticals
Synta Pharmaceuticals Corp. is a biopharmaceutical company focused on
discovering, developing, and commercializing small molecule drugs to extend
and enhance the lives of patients with severe medical conditions, including
cancer and chronic inflammatory diseases. Synta has a unique chemical compound
library, an integrated discovery engine, and a diverse pipeline of clinical-
and preclinical-stage drug candidates with distinct mechanisms of action and
novel chemical structures. All Synta drug candidates were invented by Synta
scientists using our compound library and discovery capabilities. For more
information, please visit www.syntapharma.com.
Synta Pharmaceuticals Corp.
George Farmer, 781-541-7125
Press spacebar to pause and continue. Press esc to stop.